Malaria caused by Plasmodium falciparum is a major public health problem in the developing countries of the world. Clinical treatment of malaria has become complicated due to the occurrence of infections caused by drug resistant parasites. Secondary metabolites from fungi are an attractive source of chemotherapeutic agents. This work reports the isolation and in vitro antiplasmodial activities of peptide antibiotics of fungal origin. The three peptide antibiotics used in this study were efrapeptins, zervamicins, and antiamoebin. The high-performance liquid chromatography-purified peptides were characterized by nuclear magnetic resonance and mass spectral analysis. All three fungal peptides kill P. falciparum in culture with 50% inhibitory concentrations in the micromolar range. A possible mode of action of these peptide antibiotics on P. falciparum is presented.Malaria is a major tropical disease that affects more than 300 million people living in the developing countries of the world (21, 24). The widespread occurrence of drug-resistant Plasmodium falciparum infection necessitates the urgent development of new chemotherapeutic agents. Secondary metabolites produced by fungi are often novel molecules with large potential for chemotherapeutic applications. Our aim has been to isolate, characterize, and screen fungal metabolites for their antimalarial properties. The secondary metabolites studied in this paper are efrapeptins, zervamicins, and antiamoebin. Table 1 lists the sequences of the peptides used in this study along with the fungal species that produce them. These compounds are peptide antibiotics, 16 amino acids long, that contain the unusual amino acids ␣-aminoisobutyric acid, isovaline, -alanine, and hydroxyproline. Efrapeptins are produced by the fungus Tolypocladium niveum subsp. inflatum and are inhibitors of mitochondrial F 0 F 1 ATPase, some bacterial ATP synthases, and photophosphorylation in plants (1,13,14). The ATPase of the protozan parasite Trypanosoma cruzi is also inhibited by efrapeptins (7). Recently, efrapeptins have also been shown to inhibit exocytosis in an ATP-independent manner in eukaryotic cells (22). Both zervamicins and antiamoebin are uncouplers of mitochondrial oxidative phosphorylation (3,5,6,18). Antiamoebin exhibits trypanocidal activity in a mouse model for trypanosomiasis (19) and has been shown to possess anthelmintic properties (30). All three peptide antibiotics also act as channel-forming ionophores (18). Vial et al. have examined numerous other ionophores for antimalarial activity and found gramicidin D to be the most promising candidate under both in vivo and in vitro conditions (11,12). This work reports the purification, spectral characterization, and antimalarial activities of efrapeptins, zervamicins, and antiamoebin. ϩ human blood was prepared in the laboratory. The constituents of the fungal culture medium were obtained from HiMedia Laboratories, Mumbai, India. Silica gel (60 to 80 m) for medium-pressure liquid chromatography (MPLC) was supplied by Büchi Labo...